» Articles » PMID: 29594317

[Prevention of Acute Kidney Injury In critically Ill Patients : Recommendations from the Renal Section of the DGIIN, ÖGIAIN and DIVI]

Overview
Date 2018 Mar 30
PMID 29594317
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Acute kidney injury (AKI) has both high mortality and morbidity.

Objectives: To prevent the occurrence of AKI, current recommendations from the renal section of the DGIIN (Deutschen Gesellschaft für Internistische Intensivmedizin und Notfallmedizin), ÖGIAIN (Österreichischen Gesellschaft für Internistische und Allgemeine Intensivmedizin und Notfallmedizin) and DIVI (Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin) are stated.

Materials And Methods: The recommendations stated in this paper are based on the current Kidney Disease Improving Global Outcomes (KDIGO) guidelines, the published statements of the "Working Group on Prevention, AKI section of the European Society of Intensive Care Medicine" and the expert knowledge and clinical experience of the authors.

Results: Currently there are no approved clinically effective drugs for the prevention of AKI. Therefore the mainstay of prevention is the optimization of renal perfusion by improving the mean arterial pressure (>65 mm Hg, higher target may be considered in hypertensive patients). This can be done by vasopressors, preferably norepinephrine and achieving or maintaining euvolemia. Hyperhydration that can lead to AKI itself should be avoided. In patients with maintained diuresis this can be done by diuretics that are per se no preventive drug for AKI. Radiocontrast enhanced imaging should not be withheld from patients at risk for AKI; if indicated, however, the contrast media should be limited to the smallest possible volume.

Citing Articles

[Mechanisms of action and clinical application of diuretics in intensive care medicine].

Lindner M, Lohmeyer J, Adam E, Zacharowski K, Weber C Anaesthesiologie. 2023; 72(10):757-770.

PMID: 37768358 DOI: 10.1007/s00101-023-01338-5.


[Acute kidney injury and COVID-19: lung-kidney crosstalk during severe inflammation].

Mayerhofer T, Perschinka F, Joannidis M Med Klin Intensivmed Notfmed. 2022; 117(5):342-348.

PMID: 35476144 PMC: 9044389. DOI: 10.1007/s00063-022-00919-3.


AKI Epidemiology and Outcomes: A Retrospective Cohort Study from the Prenephrology Era.

Asmus K, Erfurt S, Ritter O, Patschan S, Patschan D Int J Nephrol. 2021; 2021:5549316.

PMID: 33986959 PMC: 8093068. DOI: 10.1155/2021/5549316.


[Geriatric intensive care : Consensus paper of DGIIN, DIVI, DGAI, DGGG, ÖGGG, ÖGIAIN, DGP, DGEM, DGD, DGNI, DGIM, DGKliPha and DGG].

Michels G, Sieber C, Marx G, Roller-Wirnsberger R, Joannidis M, Muller-Werdan U Z Gerontol Geriatr. 2019; 52(5):440-456.

PMID: 31278486 DOI: 10.1007/s00391-019-01584-6.


Sepsis: early interventions count but not RRT!.

Klein S, Joannidis M, Forni L J Thorac Dis. 2019; 11(Suppl 3):S325-S328.

PMID: 30997210 PMC: 6424796. DOI: 10.21037/jtd.2018.12.134.


References
1.
Grafe C, Semrau S, Hein A, Beckmann M, Mackensen A, Dorje F . Dose adjustment of cisplatin, etoposide, and ifosfamide according to kidney function: a retrospective analysis and implications for medication safety. Naunyn Schmiedebergs Arch Pharmacol. 2018; 391(2):219-229. DOI: 10.1007/s00210-017-1456-2. View

2.
Hoste E, Bagshaw S, Bellomo R, Cely C, Colman R, Cruz D . Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015; 41(8):1411-23. DOI: 10.1007/s00134-015-3934-7. View

3.
Cho J, Shim J, Soh S, Kim M, Kwak Y . Perioperative dexmedetomidine reduces the incidence and severity of acute kidney injury following valvular heart surgery. Kidney Int. 2015; 89(3):693-700. DOI: 10.1038/ki.2015.306. View

4.
Zhou C, Gong J, Chen D, Wang W, Liu M, Liu B . Levosimendan for Prevention of Acute Kidney Injury After Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials. Am J Kidney Dis. 2015; 67(3):408-16. DOI: 10.1053/j.ajkd.2015.09.015. View

5.
Lewicki M, Ng I, Schneider A . HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass. Cochrane Database Syst Rev. 2015; (3):CD010480. PMC: 10788137. DOI: 10.1002/14651858.CD010480.pub2. View